National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

Read this book online, free! Click here to proceed to linked table of contents

New Vaccine Development:

Establishing Priorities: Volume II, Diseases of Importance in Developing Countries

Book Cover

Status: Available Now

Size: 432 pages, 8 1/2 x 11

Publication Year:1986


E-mail this page
Print List Price    
Order online and save 10%
PAPERBACK
ISBN-10: 0-309-03679-8
ISBN-13: 978-0-309-03679-5
$43.50   Add to Cart
PDF     About PDF

Authors:
Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Division of International Health
Authoring Organizations

Description:
Common diseases cost the developing world an enormous amount in terms of human life, health, and productivity, as well as lost economic potential. New and effective vaccines could not only improve the quality of life for millions of residents in ...
Read More


Paste into your Web page:

Preview
Free Resources
Read

Full Text
Jump to this book's table of contents to begin reading online for free.

Research Tools
Download Free

PDF Summary
Download the summary in PDF.

Rights & Permissions

Reprint Permission
Request permission to license or reprint the book's content through Copyright Clearance Center's Rightslink.

Request Permission to Distribute a PDF

Request Translation Rights

Questions About Rights and Permissions?

Table of Contents
Select a link below to start reading online free!
Front Matter i-xvi  
1. Summary 1-18 (skim)
2. Priority Setting for Health-Related Investments: A Review of Methods 19-29 (skim)
3. Overview of the Analytic Approach 30-43 (skim)
4. Comparison of Disease Burdens 44-62 (skim)
5. Predictions of Vaccine Development 63-75 (skim)
6. Assessing the Likely Utilization of New Vaccines 76-81 (skim)
7. Calculation and Comparison of the Health Benefits and Differential Costs Associated with Candidate Vaccines 82-105 (skim)
8. Additional Issues in the Selection of Priorities for Accelerated Vaccine Development 106-120 (skim)
9. Findings, Conclusions, and Recommendations 121-142 (skim)
Appendix A: Selection of Vaccine Candidates for Accelerated Development 143-148 (skim)
Appendix B: The Burden of Disease Resulting from Acute Respiratory Illness 149-158 (skim)
Appendix C: The Burden of Disease Resulting from Diarrhea 159-169 (skim)
Appendix D-1: The Prospects for Immunizing Against Dengue Virus 170-177 (skim)
Appendix D-2: The Prospects for Immunizing Against Escherichia coli 178-185 (skim)
Appendix D-3: The Prospects for Immunizing Against Hemophilus influenzae Type b 186-196 (skim)
Appendix D-4: The Prospects for Immunizing Against Hepatitis A Virus 197-207 (skim)
Appendix D-5: The Prospects for Immunizing Against Hepatitis B Virus 208-222 (skim)
Appendix D-6: The Prospects for Immunizing Against Japanese Encephalitis Virus 223-240 (skim)
Appendix D-7: The Prospects for Immunizing Against Mycobacterium leprae 241-250 (skim)
Appendix D-8: The Prospects for Immunizing Against Neisseria meningitidis 251-266 (skim)
Appendix D-9: The Prospects for Immunizing Against Parainfluenza Viruses 267-274 (skim)
Appendix D-10: The Prospects for Immunizing Against Plasmodium spp. 275-286 (skim)
Appendix D-11: The Prospects for Immunizing Against Rabies Virus 287-298 (skim)
Appendix D-12: The Prospects for Immunizing Against Respiratory Syncytial Virus 299-307 (skim)
Appendix D-13: The Prospects for Immunizing Against Rotavirus 308-318 (skim)
Appendix D-14: The Prospects for Immunizing Against Salmonella typhi 319-328 (skim)
Appendix D-15: The Prospects for Immunizing Against Shigella spp. 329-337 (skim)
Appendix D-16: The Prospects for Immunizing Against Streptococcus Group A 338-356 (skim)
Appendix D-17: The Prospects for Immunizing Against Streptococcus pneumoniae 357-375 (skim)
Appendix D-18: The Prospects for Immunizing Against Vibrio cholerae 376-389 (skim)
Appendix D-19: The Prospects for Immunizing Against Yellow Fever 390-402 (skim)
Appendix E: Questionnaire for Assessing Morbidity-Mortality Trade-Offs 403-411 (skim)
Appendix F: Technical Notes 412-412 (skim)
Appendix G: Biographical Notes on Committee Members 413-417 (skim)
Appendix H: Additional Sources of Advice to the Committee 418-419 (skim)
Appendix I: Contents of Supplement to Volume II 420-420 (skim)
Appendix J: Preface to Volume I 421-422 (skim)
Appendix K: Contents to Volume I 423-423 (skim)
Index 424-432 (skim)

Description

Common diseases cost the developing world an enormous amount in terms of human life, health, and productivity, as well as lost economic potential. New and effective vaccines could not only improve the quality of life for millions of residents in developing countries, they could also contribute substantially to further economic development. Using data from the World Health Organization and other international agencies, this book analyzes disease burdens, pathogen descriptions, geographic distribution of diseases, probable vaccine target populations, alternative control measures and treatments, and future prospects for vaccine development. New Vaccine Development provides valuable insight into immunological and international health policy priorities.

Search This Book

»Find more like this book

SIGN UP FOR...

New Title Emails
Read about the newest releases and receive special offers.